# An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal Tumors

> **NCT07743749** · — · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 900 (estimated)

## Conditions studied

- Renal Tumor
- Kidney Neoplasm

## Interventions

- **DIAGNOSTIC_TEST:** MRI-Based Artificial Intelligence Analysis

## Key facts

- **NCT ID:** NCT07743749
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2026-08-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07743749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07743749, "An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07743749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
